Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OsteoporeASX:OSX +25.00% Operating Cash Flow per Share is A$-0.01 as of Dec. 2025. The stock has 7 warning signs investors should review. Among 651 Medical Devices & Instruments companies, Osteopore ranks better than 84.49% on this metric.
Osteopore's operating cash flow per share for the
six
months ended in Dec. 2025 was A$-0.01.
Osteopore's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 46.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Osteopore's Operating Cash Flow per Share or its related term are showing as below:
ASX:OSX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -13.9 Med: 21.35 Max: 46.3
Current: 46.3
During the past 8 years, Osteopore's highest 3-Year average Operating Cash Flow per Share Growth Rate was 46.30% per year. The lowest was -13.90% per year. And the median was 21.35% per year.
ASX:OSX's 3-Year OCF Growth Rate is ranked better than 84.49% of 651
companies
in the Medical Devices & Instruments industry
Industry Median: 12.5
vs ASX:OSX: 46.30
Osteopore Operating Cash Flow per Share Related Terms
Osteopore Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Osteopore's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:OSX vs ISRG, BDX, RMD: Operating Cash Flow per Share Comparison
For the Medical Instruments & Supplies subindustry, Osteopore's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osteopore Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Osteopore's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of A$-0.01 mean?
Osteopore (ASX:OSX) has a Operating Cash Flow per Share of A$-0.01 as of Dec. 2025. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Osteopore and its competitors. According to the industry distribution chart, Osteopore ranks #101 out of 651 companies in the Medical Devices & Instruments industry, placing it in the top 15.5%.
Is Osteopore's Operating Cash Flow per Share too high?
Osteopore's current Operating Cash Flow per Share is A$-0.01. Based on the distribution chart, Osteopore ranks #101 out of 651 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Osteopore's Operating Cash Flow per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Osteopore ranks #101 out of 651 companies for Operating Cash Flow per Share. This places Osteopore in the top 16% of its industry — outperforming the majority of peers. The industry median Operating Cash Flow per Share is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.50, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Osteopore and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osteopore's current Operating Cash Flow per Share is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 75% below its estimated fair value. The current Operating Cash Flow per Share is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Operating Cash Flow per Share is A$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OSX has been successfully added to your 
